These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 24012160

  • 1. The dipeptidyl peptidase-4 inhibitor-sitagliptin modulates calcium dysregulation, inflammation, and PPARs in hypertensive cardiomyocytes.
    Lee TI, Kao YH, Chen YC, Huang JH, Hsu MI, Chen YJ.
    Int J Cardiol; 2013 Oct 15; 168(6):5390-5. PubMed ID: 24012160
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
    Sun L, Ke Y, Zhu CY, Tang N, Tian DK, Gao YH, Zheng JP, Bian K.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2305-11. PubMed ID: 19080338
    [Abstract] [Full Text] [Related]

  • 3. Rosiglitazone induces arrhythmogenesis in diabetic hypertensive rats with calcium handling alteration.
    Lee TI, Chen YC, Kao YH, Hsiao FC, Lin YK, Chen YJ.
    Int J Cardiol; 2013 May 10; 165(2):299-307. PubMed ID: 21917327
    [Abstract] [Full Text] [Related]

  • 4. Cardiac peroxisome-proliferator-activated receptor expression in hypertension co-existing with diabetes.
    Lee TI, Kao YH, Chen YC, Pan NH, Lin YK, Chen YJ.
    Clin Sci (Lond); 2011 Oct 10; 121(7):305-12. PubMed ID: 21501116
    [Abstract] [Full Text] [Related]

  • 5. Cardiac metabolism, inflammation, and peroxisome proliferator-activated receptors modulated by 1,25-dihydroxyvitamin D3 in diabetic rats.
    Lee TI, Kao YH, Chen YC, Tsai WC, Chung CC, Chen YJ.
    Int J Cardiol; 2014 Sep 10; 176(1):151-7. PubMed ID: 25062566
    [Abstract] [Full Text] [Related]

  • 6. Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats.
    Giannocco G, Oliveira KC, Crajoinas RO, Venturini G, Salles TA, Fonseca-Alaniz MH, Maciel RM, Girardi AC.
    Eur J Pharmacol; 2013 Jan 05; 698(1-3):74-86. PubMed ID: 23051671
    [Abstract] [Full Text] [Related]

  • 7. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, Xu G, Pu Y, Zhu Z, Xu A, Lam KS, Chen ZY, Ng CF, Yao X, Huang Y.
    Hypertension; 2012 Sep 05; 60(3):833-41. PubMed ID: 22868389
    [Abstract] [Full Text] [Related]

  • 8. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
    Jackson EK, Mi Z, Tofovic SP, Gillespie DG.
    Hypertension; 2015 Jan 05; 65(1):238-49. PubMed ID: 25368027
    [Abstract] [Full Text] [Related]

  • 9. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan 05; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 10. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
    Baumann M, Janssen BJ, Hermans JJ, Peutz-Kootstra C, Witzke O, Smits JF, Struijker Boudier HA.
    J Hypertens; 2007 Jan 05; 25(1):207-15. PubMed ID: 17143193
    [Abstract] [Full Text] [Related]

  • 11. Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats.
    Pacheco BP, Crajoinas RO, Couto GK, Davel AP, Lessa LM, Rossoni LV, Girardi AC.
    J Hypertens; 2011 Mar 05; 29(3):520-8. PubMed ID: 21150640
    [Abstract] [Full Text] [Related]

  • 12. [Expression of peroxisome proliferator-activated receptors Y changes with age in vascular smooth muscle cells of spontaneously hypertensive rat].
    Di ZL, Niu XL, Wei J, Li YQ, Chen GL, Wang NP.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar 05; 37(2):204-7. PubMed ID: 16608075
    [Abstract] [Full Text] [Related]

  • 13. Renoprotective effect of sitagliptin against hypertensive nephropathy induced by chronic administration of L-NAME in rats: role of GLP-1 and GLP-1 receptor.
    Abd El Motteleb DM, Elshazly SM.
    Eur J Pharmacol; 2013 Nov 15; 720(1-3):158-65. PubMed ID: 24238127
    [Abstract] [Full Text] [Related]

  • 14. A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.
    Satoh-Asahara N, Sasaki Y, Wada H, Tochiya M, Iguchi A, Nakagawachi R, Odori S, Kono S, Hasegawa K, Shimatsu A.
    Metabolism; 2013 Mar 15; 62(3):347-51. PubMed ID: 23062489
    [Abstract] [Full Text] [Related]

  • 15. Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
    Tofovic DS, Bilan VP, Jackson EK.
    Clin Exp Pharmacol Physiol; 2010 Jul 15; 37(7):689-91. PubMed ID: 20374254
    [Abstract] [Full Text] [Related]

  • 16. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
    Klimas J, Vaja V, Vercinska M, Kyselovic J, Krenek P.
    Basic Clin Pharmacol Toxicol; 2012 Oct 15; 111(4):279-88. PubMed ID: 22626243
    [Abstract] [Full Text] [Related]

  • 17. Proinflammatory cytokine and ligands modulate cardiac peroxisome proliferator-activated receptors.
    Lee TI, Kao YH, Chen YC, Chen YJ.
    Eur J Clin Invest; 2009 Jan 15; 39(1):23-30. PubMed ID: 19067734
    [Abstract] [Full Text] [Related]

  • 18. Uncoupling protein-2 mediates DPP-4 inhibitor-induced restoration of endothelial function in hypertension through reducing oxidative stress.
    Liu L, Liu J, Tian XY, Wong WT, Lau CW, Xu A, Xu G, Ng CF, Yao X, Gao Y, Huang Y.
    Antioxid Redox Signal; 2014 Oct 10; 21(11):1571-81. PubMed ID: 24328731
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats.
    Diep QN, Schiffrin EL.
    Hypertension; 2001 Aug 10; 38(2):249-54. PubMed ID: 11509485
    [Abstract] [Full Text] [Related]

  • 20. TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension.
    Li HB, Li X, Huo CJ, Su Q, Guo J, Yuan ZY, Zhu GQ, Shi XL, Liu JJ, Kang YM.
    Toxicol Appl Pharmacol; 2016 Aug 15; 305():93-102. PubMed ID: 27292124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.